A detailed history of Clear Rock Advisors, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Clear Rock Advisors, LLC holds 16,427 shares of ZTS stock, worth $2.91 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares
16,427
Previous 15,113 8.69%
Holding current value
$2.91 Million
Previous $2.56 Billion 11.36%
% of portfolio
1.22%
Previous 1.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 03, 2024

BUY
$145.54 - $178.83 $191,239 - $234,982
1,314 Added 8.69%
16,427 $2.85 Billion
Q1 2024

Jun 07, 2024

BUY
$165.67 - $199.94 $58,978 - $71,178
356 Added 2.41%
15,113 $2.56 Billion
Q4 2023

Feb 12, 2024

BUY
$151.44 - $200.09 $2.23 Million - $2.95 Million
14,757 New
14,757 $2.91 Billion

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Clear Rock Advisors, LLC Portfolio

Follow Clear Rock Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Rock Advisors, LLC with notifications on news.